Jeff Sternlicht: Inflammation is The ‘Storm’ Before Atherosclerosis
Jeff Sternlicht, Emergency Physician and Medical Director at Vituity, shared a post on LinkedIn:
“Atherosclerosis is not just a cholesterol problem. It’s also an inflammation problem.
We’ve gotten very good at measuring and treating LDL and Аров.
And that matters.
But there’s another layer of risk that often goes unmeasured.
Inflammation.
hsCRP is a simple blood test that can detect that ‘storm’ long before symptoms, long before an event.
Levels above ~2 mg/L should make us pause and look deeper.
What’s becoming more clear is that even when LDL and ApoB are well controlled, residual inflammatory risk can persist.
This hasn’t always been part of routine screening, but it’s now being recognized more explicitly in newer guidelines.
In my own case, this was a major blind spot.
Lowering ApoB mattered.
But addressing inflammation changed my trajectory.
If we’re not measuring inflammation, we’re not seeing the full picture of risk.
Disclaimer:
Views are my own and not those of my employer or affiliates.
This is for educational purposes only and not medical advice.”
Stay updated with Hemostasis Today.
-
Sep 25, 2026, 12:53Bastu Odoka: What Happened to Blood Donation?
-
Sep 25, 2026, 12:43Thomas Dayspring: Reshaping the Biology of Atherosclerotic Plaques with New Therapies
-
Sep 25, 2026, 12:14Garima Sharma: Community Clinical Linkages for Better Postpartum Cardiovascular Care
-
Sep 25, 2026, 10:49Shefina S: From Presenting to Hosting at TRANSCON 2026
-
Sep 25, 2026, 10:37Michelle Leona Cecil: Hemophilia Advocacy and the Power of Community
-
Sep 25, 2026, 10:13Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD